The growth of biologics (including drugs like mAbs, GLP-1, mRNA, and vaccines) is driving the need for new solutions in terms of primary containers, delivery devices, and technologies to rise to the challenge of critical issues such as protein aggregation, inorganic extractables, underdosing, and delamination.
That’s why Stevanato Group has developed the Alba® pre-filled syringe (PFS) platform for high-value drugs. It significantly reduces development time, time to market, and the quality costs associated with any wastage of the drug product. Alba® is a breakthrough solution for silicone challenges, achieving minimized particle release and optimal drug product stability. Another rapidly growing area in the healthcare industry is GLP-1 drugs, which are transforming the treatment of diabetes and obesity. A reliable container supply, smooth operation, and safe and easy self-administration are crucial for these new drugs, so Stevanato Group has developed the Nexa® high-performance syringe system. Nexa® syringes are optimized for integration in auto-injectors and give consistent gliding and injection force, with ultra-low tungsten and glue residuals, and enhanced cosmetic quality.
Stevanato Group is also constantly investing in its portfolio of injection devices to meet the evolving needs of patients and pharma companies. Each patient therapy requires a unique solution, and that’s why the company has three very different products in its portfolio – the Alina® pen injector, the Aidaptus® autoinjector, and the Vertiva™ on-body delivery system platform. Stevanato Group also provides contract manufacturing organization (CMO) services to pharma companies to support injection device projects. Its unique approach as a one-stop-shop provider means it can cover the entire product lifecycle, from concept definition to industrial delivery and final packaging – for faster time to market and reduced total cost of ownership.
And there’s more, an advancement in the on-body delivery systems platform will be unveiled at CPHI Milan!
Stop by Stevanato Group booth #20C1 to learn more!
